Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study

  D. A. Laplaud ^{1, 2, 3} AuthorId : 853702
Author

  L. Barbin ^{3, 2} AuthorId : 1276528
Author

  C. Rousseau ^{4, 2} AuthorId : 138083
Author

  N. Jousset ² AuthorId : 1276529
Author

  Romain Casey ⁵ AuthorId : 761412

Author

  M. Debouverie AuthorId : 291313
Author

  S. Vukusic AuthorId : 441831
Author

  J. de Seze AuthorId : 363185
Author

  D. Brassat AuthorId : 637304
Author

  S. Wiertlewski AuthorId : 418175
Author

  B. Brochet AuthorId : 637264
Author

  J. Pelletier ^{6, 7} AuthorId : 1047841
Author

  P. Vermersch ⁶ AuthorId : 309259
Author

  Gilles Edan ^{8, 9} AuthorId : 1600582

Author

  C. Lebrun-Frenay AuthorId : 1026974
Author

  P. Clavelou AuthorId : 396384
Author

  E. Thouvenot AuthorId : 269007
Author

  J. -P. Camdessanche AuthorId : 1276530
Author

  Ayman Tourbah ¹⁰ AuthorId : 1256728
Author Employer institution : Hôpital Maison Blanche

  B. Stankoff AuthorId : 291310
Author

  A. Al Khedr AuthorId : 1276531
Author

  P. Cabre AuthorId : 623667
Author

  C. Papeix ¹¹ AuthorId : 637261
Author

  E. Berger AuthorId : 12407
Author

  O. Heinzlef AuthorId : 1027080
Author

  T. Debroucker AuthorId : 1276532
Author

  T. Moreau AuthorId : 64980
Author

  O. Gout AuthorId : 148152
Author

  B. Bourre AuthorId : 1276533
Author

  A. Creange AuthorId : 853720
Author

  P. Labauge AuthorId : 204490
Author

  L. Magy AuthorId : 292388
Author

  G. Defer AuthorId : 1027078
Author

  Y. Foucher AuthorId : 42575
Author